We’re excited to share another milestone in the world of diabetes care. The US Food and Drug Administration (FDA) has given the green light to the Tandem Mobi Insulin Pump by Tandem Diabetes Care on Tuesday July 11, 2023, which is set to change the game in diabetes management. With this announcement, the diabetes community can look forward to a ground-breaking product that is both the world’s smallest insulin delivery system and a beacon of technological advancement.
Mobi Insulin Pump: Key Features and Things to Know
The Mobi is packed with a range of advanced features, including:
Source: Tandem Diabetes Care
- Compact Size: The Mobi is less than half the size of the T:slim X2, allowing it to fit effortlessly into a coin pocket or to be clipped onto clothing.
- 200-Unit Insulin Cartridge: Despite its small size, the Mobi boasts a 200-unit insulin cartridge, allowing users to carry their essential insulin supply in a compact format.
- Control from an iPhone: This pump is fully controllable from a compatible iPhone, integrating diabetes management into your daily technology use for maximum convenience.
- On-Pump Button: For those who prefer manual control, the Mobi features an on-pump button for bolusing insulin.
- Hybrid Closed-Loop System: The Mobi is part of a system that includes Control-IQ technology and a compatible continuous glucose monitor (CGM). This setup can predict glucose values and adjust insulin delivery to prevent highs and lows.
- Wireless Charging and Remote Software Updates: The Mobi supports wireless charging and can receive remote software updates, simplifying its maintenance and use.
As revolutionary as these features are, there are a few important things to know about the Mobi:
- Age Limit: The Mobi has been cleared for people with diabetes aged six and older.
- Limited Release: Tandem is planning a limited release in late 2023, with full commercial availability expected in early 2024.
- Prior Authorization: If you’re interested in trying the Mobi insulin pump when it becomes available, consider speaking with your healthcare provider about any necessary steps like prior authorization.
Source: Tandem Diabetes Care
The Mobi’s clearance marks an exciting step forward in diabetes management technology. This compact, innovative device, packed with user-friendly features, brings unprecedented convenience and control to those living with diabetes. While we await its commercial release, we can anticipate how the Mobi and its future counterparts will continue to shape the landscape of diabetes care.
Stay tuned with Connected in Motion for more updates on ground-breaking advancements in diabetes management. We’ll be keeping an eye out for Mobi approvals coming to Canada!
